← All indications
Pneumonia
Infection of the lung often accompanied by inflammation.
Subtype terms (9)
More specific conditions that are subtypes of Pneumonia in the MeSH hierarchy.
- Bronchopneumonia
2 drugs experimental
- Community-Acquired Pneumonia
- Healthcare-Associated Pneumonia
47 drugs (39 approved, 8 experimental)
- Pleuropneumonia
- Pneumonia, Aspiration
19 drugs (17 approved, 2 experimental)
- Pneumonia, Bacterial
62 drugs (47 approved, 15 experimental)
- Pneumonia, Necrotizing
- Pneumonia, Pneumocystis
26 drugs (23 approved, 3 experimental)
- Pneumonia, Viral
74 drugs (46 approved, 28 experimental)
Drugs by status
Approved for this indication (48)
- levofloxacin
- metronidazole
- methylprednisolone
- ceftaroline fosamil
- linezolid
- aztreonam
- urea
- cefdinir
- cefotaxime
- cefoxitin
- cefprozil
- ceftazidime
- cilastatin
- clavulanate
- doxycycline
- prednisone
- dicloxacillin
- foscarnet
- hydrocortisone
- amoxicillin
- vitamin c
- piperacillin
- streptomycin
- telithromycin
- pentamidine
- azithromycin
- netilmicin
- clarithromycin
- bacampicillin
- cefuroxime
- +18 more
Phase 4 trials (57)
- propofol
- 23-valent pneumococcal polysaccharide vaccine
- vitamin d3
- heparin
- ambroxol
- procaine benzylpenicillin
- bifidobacterium animalis
- bosentan
- ketamine
- doripenem
- remdesivir
- hydroxychloroquine
- ritonavir
- albumin (Human)
- ivermectin
- oseltamivir
- pneumococcal 13-valent conjugate vaccine
- potassium chloride
- lidocaine
- virginiamycin
- thrombopoietin
- lopinavir
- ceftriaxone
- sorbitol
- sulfamethoxazole
- sulbactam
- bupivacaine
- tocilizumab
- pentoxifylline
- enoxaparin
- +27 more
Phase 3 trials (55)
- simvastatin
- iron
- tobramycin
- ceftobiprole
- cethromycin
- tadalafil
- etanercept
- baricitinib
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- nitric oxide
- pirfenidone
- formoterol
- Measles, Mumps and Rubella Vaccine, Live
- fostamatinib
- red blood cells
- reparixin
- rhubarb
- immune globulin (human)
- rotavirus vaccine, live, oral, pentavalent
- levobupivacaine
- siltuximab
- acetylsalicylic acid
- tedizolid phosphate
- tifacogin
- urokinase
- valganciclovir
- hepatitis a vaccine, inactivated
- ptc299
- whole blood
- ciprofloxacin
- +25 more
Phase 2 trials (50)
- mannitol
- melatonin
- 11-valent pneumococcal vaccine
- mavrilimumab
- xanthohumol
- riociguat
- aerubumab
- allostim
- aluminum
- amifostine
- amitriptyline
- captopril
- bardoxolone
- cefazolin
- silmitasertib
- ceftolozane
- folic acid
- cyanocobalamin
- ic14
- iloprost
- eptifibatide
- kbpa-101
- ly3127804
- nitazoxanide
- pb1046
- prochlorperazine
- ribavirin
- ruxolitinib
- cellulose
- umbilical cord mesenchymal stem cells
- +20 more
Phase 1 trials (30)
- cal02
- delafloxacin
- autologous natural killer cells
- montanide isa51
- ticagrelor
- polyglucosamine
- tp-271
- glucose
- endotoxin
- zileuton
- autologous microbiome
- pneumococcal protein vaccine
- salmonella typhi vaccine
- pioglitazone
- lovastatin
- sodium bicarbonate
- sargramostim
- sodium chloride
- sulopenem etzadroxil
- inosine
- 64cu-dota-ecl1i
- Protein Based Pneumococcal Vaccine
- mk-5475
- acebilustat
- recombinant human egf-rp64k
- covid-19 specific t cell derived exosomes
- fapi-46
- Gremubamab
- pbpv
- flamod
Other trials (44)
- umifenovir
- bacillus clausii
- cocoa bean
- dantrolene
- ibuprofen
- fuxiong san
- tacrolimus
- zanamivir
- guaifenesin
- hua tan san
- ozone
- caspofungin
- nystatin
- tobacco
- acetaminophen
- drotrecogin alfa, activated
- lactoferrin
- interferon alfa-1b
- xiyanping
- feng re bi fei zheng
- xiaoer qingfei heji
- zhi ke san
- amphotericin b
- human fecal microbiota
- caraway seed
- bacillus subtilis
- cefradine
- amylase
- bromhexine
- cephalexin
- +14 more
Organizations
Organization Involved with Phase 4 Indications (199)
- AstraZeneca
- Cangzhou Central Hospital
- University of Connecticut
- The Central Hospital of ZiBo City
- Nanchang University
- GlaxoSmithKline
- Jiao Tong University
- Elan Pharmaceuticals
- People's Liberation Army of China
- Ghent University
- Qingdao Municipal Hospital
- Glaxo Wellcome
- Nanyang Technological University
- Hormozgan University of Medical Sciences
- University of Queensland
- Allergan
- Department of Veteran Affairs
- Harvard University
- Griffith University
- University of Ottawa
- Chinese University of Hong Kong
- University of Toronto
- Hospital Mutua de Terrassa
- Anhui College of Traditional Chinese Medicine
- University of Texas at Houston
- Andersen Foundation
- United States Army
- Onze Lieve Vrouw Hospital
- University of Valencia
- Azad University
- +169 more
Organization Involved with Phase 3 Indications (274)
- Alexion
- Inmunotek S.L.
- University of Rochester
- Pulmo Science
- Parexel
- Centro Medico ABC
- University of Illinois at Chicago
- University of Grenoble
- Jordi Gol i Gurina Foundation
- Society for Applied Studies, New Delhi
- North China University of Science and Technology Affiliated Hospital
- Kantonsspital Aarau
- Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva
- University of California, San Diego
- University of Basel
- University of Birmingham
- University of Medicine and Dentistry of New Jersey
- Albert Einstein Israelite Hospital
- The University of Texas, Dallas
- University of Chicago
- Fundacion Miguel Servet
- Fudan University
- University of Calgary
- University of Seville
- Xijing Hospital
- National Institute for Health Research, United Kingdom
- Telethon Institute for Child Health Research
- R-Pharm
- National University of Singapore
- Gilead Sciences
- +244 more
Organization Involved with Phase 2 Indications (230)
- Rouen Normandy University
- Enlivex Therapeutics Ltd.
- Arsanis, Inc.
- University of Pisa
- Centre for Digestive Diseases, Australia
- Anbics Management-Services Ag
- Cadrock Pty. Ltd.
- Istinye University
- The University of Hong Kong
- Innate Pharma
- Hospital Rio Hortega
- Taipei Veteran General hospital
- Fondazione "Un Cuore per Milano" - a no profit foundation
- University of Lyon
- University of Arizona
- Aspire Health Science
- Magna Graecia University
- Hospital Regional da Asa Norte, Brazil
- Hospital Regional de Sorocaba Dr Adib Domingos Jatene
- Fondazione Giovanni Pascale
- JSS Medical Research Inc.
- German Jordanian University
- CH Saint Denis
- Moscow State University
- Bougainville Hospital, RSA
- JOSHA Research, RSA
- Public Health England
- QPS
- Hospital Universitario de Fuenlabrada
- Clinical Evaluation Research Unit at Kingston General Hospital
- +200 more
Organization Involved with Phase 1 Indications (56)
- Sanofi-Aventis
- Synspira, Inc.
- University of Poitiers
- US Bioscience
- Prism Research
- Wuhan Renmin University
- Azidus
- Celtaxsys, Inc.
- Government of Kuwait
- Doris Duke Charitable Foundation
- Combioxin SA
- Sage Products, Inc.
- Medical University of Vienna
- Arizona State University
- MerLion Pharmaceuticals GmbH
- Zhongyuan Union Stem Cell Bio-engineering Corporation
- Mansoura University
- University of Vienna
- NeuroActiva
- Wuhan Huoshenshan Hospital
- Takeda
- National Autonomous University of Mexico
- Cellavita Pesquisa Científica Ltda
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Erciyes University
- Tianjin Cansino Biotechnology Inc
- Pediatric Hospital Coyoacan
- Meiji Seika Pharma Co., Ltd.
- Xinxiang Medical University
- Tetraphase Pharmaceuticals
- +26 more
Organization Involved with Other Experimental Indications (93)
- Alliance Forum Foundation
- Yubari Health Care Research Center
- Hitotsubashi University
- University of Palermo
- Northern State Medical University
- Instituto Nacional de Cardiologia Ignacio Chavez
- Centers for Disease Control and Prevention, China
- Fundacion GenesisCare
- Shandong Provincial Chest Hospital
- University of Manitoba
- Cantonal Hospital of St. Gallen
- Hospital General de Niños Pedro de Elizalde
- Southeast University
- Shengjing Hospital
- Fisons
- Hospital Privado de Comunidad de Mar del Plata
- Dhaka Medical College
- National Heart Institute, Egypt
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Laval University
- University of Picardie Jules Verne
- Clinica Zabala
- Wageningen University
- Swiss Federal Institute of Technology
- National Cheng Kung University
- University of Melbourne
- Programme Against Malnutrition
- Mbarara University of Science and Technology
- WanBangDe Pharmaceutical Group Co.,Ltd.
- Capital Institute of Pediatrics, China
- +63 more